The New England Journal of Medicine: Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients Medscape: STEEPLE: Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention Patients Medscape: OASIS 5: Efficacy and Safety of Fondaparinux vs Enoxaparin in ACS Patients OASIS 5: Efficacy and Safety of Fondaparinux vs Enoxaparin in ACS Patients Nonmajor orthopedic surgery of the lower limbs that results in transient reduced mobility places patients at risk for venous thromboembolism. Rivaroxaban may be noninferior to enoxaparin with regard ... FierceBiotech: In the Prevention of VTE in Acutely ill Patients, Rivaroxaban Compares Favorably with Enoxaparin but Does Not Show a Consistent In the Prevention of VTE in Acutely ill Patients, Rivaroxaban Compares Favorably with Enoxaparin but Does Not Show a Consistent Net Clinical Benefit MAGELLAN study meets primary efficacy endpoints of ...

Understanding the Context

In the Prevention of VTE in Acutely ill Patients, Rivaroxaban Compares Favorably with Enoxaparin but Does Not Show a Consistent